Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura A Petrillo, M.D.

Concepts (122)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms112024134831.220 Why?
Carcinoma, Non-Small-Cell Lung6202453880.900 Why?
Palliative Care11202436390.790 Why?
Terminal Care4202417690.580 Why?
Euthanasia12017580.540 Why?
Suicide, Assisted12017680.530 Why?
Melanoma2202456950.460 Why?
Qualitative Research2202431380.450 Why?
Quality of Life82024134680.420 Why?
Caregivers2202423040.410 Why?
Hospice Care120186780.370 Why?
Neoplasms72024223440.360 Why?
Hypoglycemia120188960.360 Why?
Nursing Homes1201810840.350 Why?
Decision Making2202139550.250 Why?
Veterans1201826670.230 Why?
Physicians2202245910.210 Why?
California2201714350.200 Why?
Immunotherapy3202147460.190 Why?
Karnofsky Performance Status120201630.170 Why?
Practice Guidelines as Topic1201774240.170 Why?
Humans3420247661170.150 Why?
Aged, 80 and over72024595150.150 Why?
Interviews as Topic1202427410.140 Why?
Legislation, Medical12017990.140 Why?
Advance Directives120182490.130 Why?
Gene Expression Profiling1201295270.130 Why?
Gene Expression Regulation, Neoplastic1201286120.130 Why?
Death120216860.130 Why?
Uncertainty120217630.130 Why?
Patient-Centered Care2202414470.120 Why?
Aged1120241712190.120 Why?
Attitude of Health Personnel2202039280.120 Why?
Adult920242231390.110 Why?
Diabetes Mellitus, Type 212018122350.110 Why?
Pandemics3202287250.100 Why?
Emergency Medicine1202212220.100 Why?
Retinal Dehydrogenase12012780.100 Why?
Immunologic Factors1202115920.100 Why?
Focus Groups1201814590.100 Why?
Middle Aged1020242230830.090 Why?
Emergency Service, Hospital5202278710.090 Why?
Advance Care Planning120186980.090 Why?
Prognosis22022299120.090 Why?
Survivors1202123750.090 Why?
Medical Oncology1202123390.080 Why?
Multigene Family1201210810.080 Why?
Physician-Patient Relations1202232700.080 Why?
Female1220243962330.070 Why?
Hip Fractures120169950.070 Why?
Communication1202239090.070 Why?
Isoenzymes1201216880.070 Why?
Male1020243639350.070 Why?
Survival Analysis12020100870.070 Why?
Mice, SCID1201226260.070 Why?
Paroxetine120081810.070 Why?
Activities of Daily Living1201624190.070 Why?
Retrospective Studies62024815650.070 Why?
Recovery of Function1201629710.060 Why?
Logistic Models12020132730.060 Why?
Hot Flashes120083300.060 Why?
Breast Neoplasms12012210740.060 Why?
Inhibin-beta Subunits12004270.060 Why?
Follicle Stimulating Hormone, beta Subunit12004580.060 Why?
Xenograft Model Antitumor Assays1201236040.060 Why?
Pancreatic Neoplasms1202154540.050 Why?
Depression2202282300.050 Why?
Cost of Illness2202419490.050 Why?
Chronic Disease1201893540.050 Why?
Activins120042100.050 Why?
Coronavirus Infections1202031110.050 Why?
Pneumonia, Viral1202032330.050 Why?
Lung12021100630.050 Why?
Receptor, erbB-21201225930.050 Why?
Cross-Sectional Studies12021262900.040 Why?
Incidence12018215130.040 Why?
Inpatients2202125660.040 Why?
Gonadotropin-Releasing Hormone1200411420.040 Why?
Transcriptional Activation1200417430.040 Why?
Clinical Trials as Topic2202480380.040 Why?
Patient Care Planning120229030.030 Why?
Treatment Outcome42022652190.030 Why?
United States22023729200.030 Why?
Forecasting1202229360.030 Why?
Mobility Limitation120164090.030 Why?
Consensus1202232020.020 Why?
Adaptation, Psychological1202226620.020 Why?
Molecular Targeted Therapy1202228240.020 Why?
Neoplasm Staging12024112000.020 Why?
Walking1201611980.020 Why?
Prospective Studies22024548120.020 Why?
Geriatric Assessment1201614220.020 Why?
Massachusetts1202188820.020 Why?
Healthcare Disparities1202334070.020 Why?
Mice22012818390.020 Why?
Health Services Accessibility1202355100.020 Why?
Disease Progression12022136160.010 Why?
Smad2 Protein120041440.010 Why?
Smad3 Protein120041650.010 Why?
Single-Blind Method1200815880.010 Why?
Smad4 Protein120041940.010 Why?
Response Elements120043070.010 Why?
Animals220121688000.010 Why?
Comorbidity12016105790.010 Why?
Dementia1201627410.010 Why?
Estrogen Replacement Therapy1200812060.010 Why?
Hospitalization12021108110.010 Why?
Longitudinal Studies12016147470.010 Why?
Age Factors12016183860.010 Why?
Cohort Studies12021416840.010 Why?
MAP Kinase Signaling System1200414900.010 Why?
Binding Sites1200460010.010 Why?
Trans-Activators1200428490.010 Why?
Double-Blind Method12008124260.010 Why?
Base Sequence12004124050.010 Why?
Promoter Regions, Genetic1200457840.010 Why?
Molecular Sequence Data12004175970.010 Why?
Cell Line12004155460.010 Why?
Nuclear Proteins1200457910.010 Why?
Rats12004237170.000 Why?
DNA-Binding Proteins1200496010.000 Why?
Mutation12004302090.000 Why?
Petrillo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Explore
_
Co-Authors (60)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.